A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease
Clinical trial NCT04971733 · COMPLETED
Trial details
- NCT number
- NCT04971733
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-28
- Primary completion
- 2024-05-24
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.